Harvard Bioscience (HBIO) Net Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -142.00 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -916.00 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -40.00 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 365.00 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -597.00 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 196.00 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 132.00 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -229.00 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -146.00 |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | 21,448.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,448.00 |
| Dec 31, 2025 | -1,440.00 |
| Sep 30, 2025 | 1,588.00 |
| Jun 30, 2025 | 131.00 |
| Mar 31, 2025 | -21,183.00 |
| Dec 31, 2024 | 572.00 |
| Sep 30, 2024 | -1,697.00 |
| Jun 30, 2024 | -906.00 |
| Mar 31, 2024 | -2,122.00 |
| Dec 31, 2023 | 196.00 |
| Sep 30, 2023 | 776.00 |
| Jun 30, 2023 | -1,174.00 |
| Mar 31, 2023 | 2,611.00 |
| Dec 31, 2022 | -940.00 |
| Sep 30, 2022 | -1,207.00 |
| Jun 30, 2022 | 982.00 |
| Mar 31, 2022 | -2,156.00 |
| Dec 31, 2021 | 407.00 |
| Sep 30, 2021 | 407.00 |
| Jun 30, 2021 | 530.00 |
| Mar 31, 2021 | 1,652.00 |
| Dec 31, 2020 | -406.00 |
| Dec 31, 2019 | 308.00 |
| Dec 31, 2018 | -597.00 |
| Jun 30, 2018 | -114.00 |
| Mar 31, 2018 | 846.00 |
| Dec 31, 2017 | 966.00 |
| Sep 30, 2017 | 777.00 |
| Jun 30, 2017 | 397.00 |
| Mar 31, 2017 | 57.00 |
| Dec 31, 2016 | 5,542.00 |
| Sep 30, 2016 | -326.00 |
| Jun 30, 2016 | -394.00 |
| Mar 31, 2016 | 308.00 |
| Dec 31, 2013 | 572.00 |
| Dec 31, 2012 | -1,006.00 |
| Dec 31, 2011 | 1,833.00 |
| Sep 30, 2011 | -4,802.00 |
| Jun 30, 2011 | -222.00 |